Breast cancer is the most common cause of cancer in women and the second most common cause of cancer death in women in the U.S. While the majority of new breast cancers are diagnosed as a result of an abnormality seen on a mammogram, a lump or change in consistency of the breast tissue can also be a warning sign of the disease. Heightened awareness of breast cancer risk in the past decades has led to an increase in the number of women undergoing mammography for screening, leading to detection of cancers in earlier stages and a resultant improvement in survival rates. Still, breast cancer is the most common cause of death in women between the ages of 45 and 55.This book presents the latest research in the field.
Preface; The HER2 Oncogene in Breast Cancer; Multi-Drug Resistance as a Problem Challenging Breast Cancer Chemotherapy; Elapsed Time in the Management of Early Stage Breast Cancer; Signal Transduction & Metastasis Suppression:: The Role of Raf Kinase Inhibitor Protein (RKIP) in Breast Cancer ; BRCA1-Associated Proteins:: Novel Targets for Breast Cancer Radiation Therapy; Peripheral Benzodiazepine Receptor as a Biomarker for Breast Cancer; Phospholipids as Biomarkers for Breast Cancer; Genetically Engineered T-Cells for Adoptive Immunotherapy of Breast Cancer; Trastuzumab Resistance; Lymphatic Spreading Propensity & Aberrant MUC1 Bearing TN/TN-Like Carbohydrate of Aggressive Breast Cancer Cells; Commentary:: Relationship between Carbohydrate Expression Profiles of Cancer Cells & Prognosis of Breast Cancer Patients; Index.
Komentarze (0)
Chwilowo nie możesz polubić tej opinii
Zgłoś komentarz
Czy jesteś pewien, że chcesz zgłosić ten komentarz?
Zgłoszenie wysłane
Twój komentarz został wysłany i będzie widoczny po zatwierdzeniu przez moderatora.